Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 70518-4051

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 70518-4051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Quetiapine Extended Release 150 mg film-coated tablets by RemedyRepack Inc. The container holds 30 tablets. Directions and storage temperatures are noted, along with manufacturer ScieGen Pharmaceuticals, Inc., in Hauppauge, NY, and repackager contact information. The label emphasizes swallowing whole without splitting, crushing, or chewing.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A line graph depicting the proportion of patients with relapse (%) over time in months. The graph compares two groups labeled PLA and QTP XR, showing their relapse progression throughout a 7-month period.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A line graph depicting the proportion of patients with relapse (%) over time (weeks). Two curves are shown: one for CTP + LIVIAL and another for PLA + LIVIAL, illustrating differences in relapse rates across approximately 100 weeks.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A survival curve graph depicting the proportion of patients with relapse over time in weeks. Two lines represent different treatment groups: one labeled QTP + LIVAL and the other PLA + LIVAL. The graph shows relapse proportions increasing over a period of approximately 100 weeks, with QTP + LIVAL having a higher relapse rate compared to PLA + LIVAL.*

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure of quetiapine illustrating its core molecular framework along with a separate structure representing its acidic counterion, consistent with the active ingredient in Quetiapine Extended Release 150 mg tablets by RemedyRepack Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.